Novartis Investigative Site

San Sebastián de los Reyes, Madrid 28703

0 studies enrolling now · 6 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Chronic Heart Failure (CHF), Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia, Heart Failure With Preserved Ejection Fraction, Heart Failure With Reduced Ejection Fraction (HF-rEF)

Studies at this site

• Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction — Completed
• Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. — Completed
• Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia — Completed
• A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients — Completed
• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor — Completed